Related Articles
The effect of palonosetron hydrochloride in the prevention of chemotherapy-induced moderate and severe nausea and vomiting
Comparative investigation of the anti-emetic effects of granisetron and palonosetron during the treatment of acute myeloid leukemia
Palonosetron exhibits higher total control rate compared to first‑generation serotonin antagonists and improves appetite in delayed‑phase chemotherapy‑induced nausea and vomiting
Comparison between the antiemetic effects of palonosetron and granisetron in breast cancer patients treated with anthracycline‑based regimens
A phase II, randomized study of aprepitant in the prevention of chemotherapy‑induced nausea and vomiting associated with moderately emetogenic chemotherapies in colorectal cancer patients